| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/22/2007 | US7220862 Calcitonin gene related peptide receptor antagonists |
| 05/22/2007 | US7220860 Anticancer agents |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220853 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220833 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 05/22/2007 | US7220784 Substituted stilbenes and their reactions |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | US7220782 Reducing the sensitivity of endothelially- compromised vascular smooth muscle by administering a pharmaceutically effective amount of a CLC3 chloride channel blocker, or a pharmaceutically acceptable salt thereof |
| 05/22/2007 | US7220780 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 05/22/2007 | US7220779 Using 5-aminolevulinic acid |
| 05/22/2007 | US7220778 Methods and devices for epithelial protection during photodynamic therapy |
| 05/22/2007 | US7220777 Lactam derivatives as antagonists for human 11cby receptors |
| 05/22/2007 | US7220776 N-[(S)-ethoxycarbonyl-1-butyl]-(S)-alanine is reacted with carbonyldiimidazole to produce Ethyl (2S)-2-[(4S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]pentanoate; reacted with (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylic acid; hydrogenation; salt formation |
| 05/22/2007 | US7220775 Compound useful for the treatment of neuropathic pain |
| 05/22/2007 | US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 05/22/2007 | US7220772 Pyrazole derivatives |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220767 Pharmaceutical formulations containing zolmitriptan |
| 05/22/2007 | US7220766 3-phenylpropionic acid derivatives |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220764 Sphingosine kinase inhibitors |
| 05/22/2007 | US7220763 Indole-type derivatives as inhibitors of p38 kinase |
| 05/22/2007 | US7220762 Methods for stabilizing benzimidazole compounds |
| 05/22/2007 | US7220761 Compounds and methods for controlling fungi, bacteria and insects |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
| 05/22/2007 | US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors |
| 05/22/2007 | US7220757 Topically administering to the patient an antibacterially effective amount compounds such as N-(4,5-Dibromothien-2-ylmethyl)-N'-(1H-imidazo[4,5-b]pyridine-2-yl)-propane-1,3-diamine for therapy of bacterial infection |
| 05/22/2007 | US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 05/22/2007 | US7220755 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220751 E.g., Cis-4-amino-cis-2-methyl-N-(6-methyl-2-(2-(2-pyridyl) ethenyl) quinazolin-4-yl)cyclohexylamine trihydrochloride; a nociceptin opiod-receptor agonist or antagonist effecting chronic pain and allodynia accompanied with herpes zoster |
| 05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
| 05/22/2007 | US7220749 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/22/2007 | US7220748 Administering, to a patient in need of such treatment, an effective amount of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof |
| 05/22/2007 | US7220747 Selected from the group consisting of alloxazines and photosensitizers |
| 05/22/2007 | US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 05/22/2007 | US7220745 Viricides; therapy for hepatitis virus infections |
| 05/22/2007 | US7220744 Monocyclic substituted phenyl methanones |
| 05/22/2007 | US7220743 Heterocyclic CB1 receptor antagonists |
| 05/22/2007 | US7220742 For therapy of respiratory complaints |
| 05/22/2007 | US7220741 As cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters, for therapy of central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders |
| 05/22/2007 | US7220740 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220738 Rifamycin analogs and uses thereof |
| 05/22/2007 | US7220737 Administering systemically an effective amount of noribogaine or its pharmaceutically acceptable salt to patient effective to reduce or eliminate nociceptive pain |
| 05/22/2007 | US7220736 Pyrimidine compounds |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists |
| 05/22/2007 | US7220733 Separating conjugated estrogens from pregnant mares' urine, using pervaporation on pore-free silicone membrane; hormone replacement therapy |
| 05/22/2007 | US7220732 Compounds useful as photodynamic therapeutic agents |
| 05/22/2007 | US7220731 Trisaccharide or higher polysaccharide; systems useful for dissolution, encapsulation, storage and delivery of therapeutic and diagnostic molecules |
| 05/22/2007 | US7220729 Huntington's Disease Treatment |
| 05/22/2007 | US7220727 Aminoglycosides as antibiotics |
| 05/22/2007 | US7220726 Antifungal pimaricin compositions and therapeutic methods employing same |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site |
| 05/22/2007 | US7220561 Using transgenic bacillus to ferment vitamin b5, valine and isoleucine |
| 05/22/2007 | US7220435 Process for the production of glycine enriched NaCI crystals with improved flow |
| 05/22/2007 | US7220434 Dual-release compositions of a cyclooxygenase-2 inhibitor |
| 05/22/2007 | US7220432 Vegetable substitute for lanolin |
| 05/22/2007 | US7220431 Methods and compositions for applying pharmacologic agents to the ear |
| 05/22/2007 | US7220428 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 05/22/2007 | US7220427 Mixture for transdermal delivery of low and high molecular weight compounds |
| 05/22/2007 | US7220425 Method for therapy of liver tumors |
| 05/22/2007 | US7220424 For topical application, penetration |
| 05/22/2007 | US7220423 Using a genetic vaccine that codes for conserved domains 2, 3 and 5 of a major outer membrane protein (MOMP) of a strain of Chlamydia; protection against lung infections from the strain of Chlamydia trachomatis for example |
| 05/22/2007 | US7220409 Stabilization of immunoglobulins at low pH |
| 05/22/2007 | US7220406 Method for promoting bone formation |
| 05/22/2007 | US7220403 Pharmaceutical formulation of fluticasone propionate |
| 05/22/2007 | US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 05/22/2007 | CA2389032C Preventive or therapeutic agents for inflammatory diseases of intestine |
| 05/22/2007 | CA2386406C Tissue products containing antiviral agents which are mild to the skin |
| 05/22/2007 | CA2382573C Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/22/2007 | CA2361844C Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry |
| 05/22/2007 | CA2341303C Gelatinous body protection article having a therapeutic effect |
| 05/22/2007 | CA2339942C Extended release acetaminophen |
| 05/22/2007 | CA2333420C Silk clothes for protecting affected parts |
| 05/22/2007 | CA2325033C Use of ribose to treat fibromyalgia |
| 05/22/2007 | CA2323680C Orally disintegrable tablets |
| 05/22/2007 | CA2321560C The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 05/22/2007 | CA2307632C Aqueous liquid pharmaceutical composition |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2275353C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 05/22/2007 | CA2266363C Corneal subepithelial opacity inhibitor |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2243522C Preparations of non-steroidal analgesics |
| 05/22/2007 | CA2242562C Human dnase resistant to actin inhibition |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2227443C Granular preparation and producing process thereof |
| 05/22/2007 | CA2219692C S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |